-APAIC web traffic report October 2007 (pdf. 0.4mb)


Patterns and Trends in Amphetamine-Type Stimulantsin East Asia and the Pacific 2006
(pdf, 5.5 mb)


 
 
 





Introduction to drug control

Drug control refers to governmental laws and international regulations pertaining to the manufacture, distribution, and use of drugs. Drug policies are designed to affect the supply and/or the demand for illegal drugs locally or nationally. Policies may include education, treatment, laws, policing, and border surveillance.

The first principles of drug control are to ensure that drugs are available only for medical and scientific purposes, not for uses that compromise individual and public health. There is a grey area between these two propositions. The synthesis of a psychoactive substance may offer therapeutic utility but also, very often, a potential for abuse. If the potential is realized, it becomes necessary to put the substance under control. Technological innovation in the grey area then drives the abuse by finding ways of circumventing the control. Breaking the law and circumventing the law are two quite different propositions. The nature of the law will determine to some extent, whether loopholes will be found for circumvention: it can anticipate innovation, thereby closing the possible loopholes, or it can be simply reactive, setting in place some mechanism for modifications as and when the need arises.

This section provides a brief overview of related international agreements and frameworks:

1. United Nations Drug Control Conventions (1961, 1971, 1988)
2. Global Assessment Programme (1998)
3. ASEAN Plan of Action on Drug Abuse Control (1996)
4. ACCORD Plan of Action (2000)
5. MOU on Drug Control (1993)
6. Subregional Action Plan (2000)
7. Tokyo Conference on ATS (2000)
8. Regional Government Responses

United Nations
International drug control treaties provide the legal foundation for action against drug related offences. Many countries still lack adequate legal frameworks, which undermines both domestic and international drug control efforts. In addition, global developments in drug abuse and trafficking are dramatically increasing the legislative needs of States.

1. Prior to 1961 various United Nations Conventions have restricted the sale and use of different substances to medical purposes. These conventions were amalgamated in the 1961 Single Convention on Narcotic Drugs. This in turn was supplemented in 1972 by a Protocol stressing the need for treatment and rehabilitation services. This Convention aims to combat drug abuse by coordinated international action. There are two forms of intervention and control that work together. First, it seeks to limit the possession, use, trade, distribution, import, export, manufacture and production of drugs exclusively to medical and scientific purposes. Second, it combats drug trafficking through international cooperation to deter and discourage drug traffickers.

2. In 1971 the Convention on Psychotropic Substances established an international control system for psychotropic substances. It responded to the diversification and expansion of the spectrum of drugs of abuse and introduced controls over a number of synthetic drugs according to their abuse potential and their therapeutic value. For the purposes of international drug control, the term "drug abuse" refers to the illicit, i.e. non-medical, use of any of the substances listed in the above conventions.

3. In 1988 the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances addressed drug trafficking and included provisions against money laundering and the diversion of chemicals used in the manufacture of illicit drugs (precursor chemicals). It provides for international cooperation through, for example, extradition of drug traffickers, controlled deliveries, and transfer of proceedings.

These three major international drug control treaties are mutually supportive and complementary. In addition to including general provisions on illicit trafficking and drug abuse, they seek to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes and to prevent their diversion into illicit channels. An important purpose of the first two treaties is to codify internationally applicable control measures in order to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes, and to prevent their diversion into illicit channels.

4. At the 1998 UN General Assembly special session on the world drug problem, member states recognized that reducing the demand for drugs was an essential pillar in the stepped-up global effort to fight drug abuse and trafficking. They committed themselves to reduce significantly both the supply of and demand for drugs by 2008, as expressed in the Political Declaration on the Guiding Principles of Drug Demand Reduction.

The 1998 UN Political Declaration addresses the responsibility of nations where consumption is a problem, and it is especially important for demand reduction efforts because it gives demand reduction strategies an equal weight with supply reduction strategies. In addition, it emphasizes that demand reduction strategies should be built on knowledge acquired from research, should have community-wide participation, and should include training for policy makers. All of these elements are promoted through the UNODC RC ATS project.

Global Assessment Programme on Drug Abuse
The 1998 political declaration aims to eliminate or significantly reduce the demand for illicit drugs by 2008. Monitoring progress toward this goal requires reliable and systematic data on drug consumption, which was unavailable at a global level at that time. As a response to this need UNODC launched the Global Assessment Programme on Drug Abuse (GAP). The GAP documents have now been translated into Chinese by the National Narcotics Control Commission (NNCC), China. GAP - Chinese Translation (1.07MB) PDF .

The problems the UNODC RC ATS project is addressing are congruent with those identified under GAP. Moreover, under the project's general provisions for special consideration, emphasis is placed on integrating the principles, methods, and core indicators of GAP.

A panel of technical experts representing international bodies and regional networks met in Lisbon in January 2000 to discuss the principles, structures, and indicators necessary for effective drug information systems. At this meeting, participants considered the technical aspects of collecting reliable, accurate, and strategically valuable information on drug abuse and identified the structures necessary to support the collection and analysis of data at the national, regional, and global levels. Particular consideration was given to the development of a set of core epidemiological demand indicators against which United Nations Member States could report on their respective situations. The following list of core indicators represents the consensus expressed by the technical experts at the meeting:

1. Drug consumption among the general population
(estimates of prevalence and incidence)

2. Drug consumption among the youth population
(estimates of prevalence and incidence)

3. High-risk drug abuse
(estimates of number of drug injectors and proportion engaging in high-risk behaviours, estimates of the number of daily users)

4. Service utilization for drug problems
(number of individuals seeking help for a drug problem)

5. Drug-related morbidity
(HIV, HBV and HCV prevalence among illicit drug consumers)

6. Drug-related mortality
(deaths directly attributable to drug consumption)

ASEAN Plan of Action on Drug Abuse Control
The project falls within the intent of the demand reduction element of the ASEAN Plan of Action on Drug Abuse Control.

The Association of Southeast Asian Nations (ASEAN) Plan of Action on Drug Abuse Control has been operating since 1996 and has since had 15 projects related to illicit drug abuse. ASEAN's current members are Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, and Thailand.

The ASEAN Declaration states that the aims and purposes of the Association are: (i) to accelerate the economic growth, social progress, and cultural development in the region through joint endeavours in the spirit of equality and partnership in order to strengthen the foundation for a prosperous and peaceful community of Southeast Asian nations, and (ii) to promote regional peace and stability through abiding respect for justice and the rule of law in the relationship among countries in the region and adherence to the principles of the United Nations Charter.

ACCORD Plan of Action
The project supports the objectives and goals of the ACCORD Plan of Action covering the ASEAN countries and China.

The ACCORD Plan of Action enables a cooperative network to respond to the dangers of new drugs, and to measure their changes. The ACCORD Plan of Action was unanimously endorsed by 378 participants from 36 countries and 16 organizations at the International Congress "In pursuit of drug free ASEAN 2015: sharing the vision, leading the change" in Bangkok, Thailand, October 2000. The implementation of the Plan of Action will be coordinated by UNODC and the ASEAN Secretariat".

The ACCORD partners include all of the UNODC RC ATS project members (Cambodia, China, Lao PDR, Myanmar, Philippines, Thailand, Vietnam), as well as Brunei Darussalam, Indonesia, Malaysia, and Singapore.

Memorandum of Understanding on Drug Control
The project also is consistent with the intent of the Memorandum of understanding on drug control.

In 1993 the Governments of the Mekong Subregion determined that concerted international efforts were required to address the problems of illicit drug production, trafficking, and abuse. As a result, the Governments of the Lao People’s Democratic Republic, the Union of Myanmar, the Kingdom of Thailand, the People’s Republic of China, and UNODC signed a Memorandum of Understanding (MOU). In 1995 Cambodia and Vietnam joined the MOU.

The Memorandum of Understanding is a non-binding agreement which allows governments and agencies, such as customs or police, to work together. Ideally this form of cooperation deepens and broadens in scope over time. UNODC has brokered MOUs in many regions of the world, resulting in cooperation in intelligence gathering, harmonized legal and institutional frameworks, joint enforcement operations, and demand reduction efforts. The MOU of Southeast Asia was the first of its kind.

Subregional Action Plan
One of the major outcomes of the MOU of Southeast Asia meetings was the approval of a Subregional Action Plan (SAP) comprising collaborative drug control projects in the areas of demand reduction, supply reduction, and law enforcement. It was determined that all six governments (Cambodia, China, Lao PDR, Myanmar, Thailand, and Vietnam) and the UNODC would be involved in monitoring project progress, and steering the development of the programme through annual meetings. In 2000, the updated SAP included provision for a regional project to take action against ATS abuse.

Within the framework of the Action Plan, UNODC acts as a catalyst and coordinator of drug control activities, concentrating on broad-based and long term programmes, assisting subregional and national project formulation and execution and strengthening the planning and collaboration with other national and international institutions.

Currently, there are fourteen projects under implementation, including the UNODC RC ATS project. It is envisaged that new projects corresponding with the overall objectives and the needs of the signatory countries will be identified and included in the Plan.

Tokyo Conference on ATS
The project design is congruent with the resolution and practical measures for national and regional actions outlined by the Tokyo Conference on ATS 2000. Tokyo Conference Report (106 KB) PDF

Regional Government Responses
Assessing both drug demand and drug supply issues are critical to responding to the increase abuse of amphetamine-type stimulants. The demand issues primarily concern a lack of factual information about the risks of ATS use in social environments which accept or promote drug use as part of a fashionable image. Initial use by youth is partly driven by this image and by encouragement through peer pressure. Occupational users give the risks a lower priority in favour of immediate economic gain, and recreational users either fail to recognize the dependence producing properties of the ATS group or naively believe that they are simply not vulnerable.

Preventive measures can respond to some of these issues by providing factual information about ATS risks while also dispelling the myths about invulnerability. The nature of the information and form of presentation will depend upon the characteristics of the target population, including their pre-existing knowledge, attitudes and behaviours. Settings for prevention often include formal and non-formal education facilities and work sites.

Accessible treatment and rehabilitation services are needed for those who have developed chronic dependence upon ATS. Since the effectiveness of these interventions is largely dependent upon the motivation of the abuser, a complete assessment and treatment plan is often desirable. Relapse prevention activities and community support networks are often needed to overcome drug craving.

The supply issues centre upon the availability of cheap precursor chemicals with simple structures, illicitly diverted and converted to ATS through simple techniques. Gaps and differences in the provision of national legislation and regulations of neighbouring countries provide additional scope for clandestine manufacturing.

Back to top



Copyright © 2003-2006 UNODC TDRASF97. All Rights Reserved Legal Notice